We are live on
!
Find out more
THP
Tower House Partners Portfolio holdings
AUM
$16.8M
1-Year Est. Return
41.98%
This Fund
S&P 500
This Quarter
Est. Return
-18.86%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57.4M
AUM Growth
-$59.3M
(-51%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-65.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Azenta
AZTA
|
+$17.1M |
| 2 |
Charles River Laboratories
CRL
|
+$10.5M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
RCGV
SCM
CCA
OHU
OA
JM
OP
AC
Tower House Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Tower House Partners held 3 positions worth $57.4M, down 51% from $117M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tower House Partners withdrew a net $37.7M in Q1 2022, reducing 3 holdings. Its largest reduction was Azenta, cutting an estimated $17.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tower House Partners's biggest Q1 2022 reduction was Azenta, cutting an estimated $17.1M.
- Tower House Partners's ten largest holdings make up 100% of its $57.4M portfolio in Q1 2022.
- Tower House Partners opened 0 new positions and closed 0 in Q1 2022.
- Tower House Partners's portfolio value fell 51% quarter-over-quarter to $57.4M.
Based on Tower House Partners's 13F filing for Q1 2022, filed 16 May 2022.